Last update:

Overweight & Obesity news

Overweight & Obesity

Tirzepatide's benefits fade for most: Weight and health markers rebound after withdrawal, study finds

Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide patients. People with obesity ...

Overweight & Obesity

Metabolites produced in intestine play central role in controlling obesity and diabetes, study shows

A study conducted at Harvard University identified a group of metabolites that travel from the intestine to the liver and then to the heart, where they are pumped throughout the body. These metabolites play an important role ...

Health

Study links America's favorite cooking oil to obesity

Soybean oil, the most widely consumed cooking oil in the United States and a staple of processed foods, contributes to obesity, at least in mice, through a mechanism scientists are now beginning to understand.

Overweight & Obesity

Everyday routines in early infancy may shape later obesity risk

In the United States, approximately 14.7 million children and adolescents between the ages of 2 and 19 are living with obesity, according to the Centers for Disease Control and Prevention. Since children living with obesity ...

Medications

Molecule: What's in this dangerous, illegal slimming pill?

It's the kind of promise that stops thumbs mid-scroll: "Take Molecule and forget food exists." Viral TikTok clips show influencers flaunting rapid weight-loss transformations, tapping into the body image concerns that leave ...

Overweight & Obesity

Gut bacterium could be key to tackling obesity crisis

The internet, libraries and bookshops are full of plans and advice on how to lose weight, from fad diets to intense exercise routines. But there could be another route to keeping the pounds away, and that's with a gut bacterium ...

Medications

FDA says shortage of GLP-1 tirzepatide is over

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over.

Neuroscience

Study finds brain enzyme inhibition reduces obesity in mice

Endocannabinoids in the brain play a key role in food intake and energy use. Modulating the action of these molecules could help fight obesity, say researchers at Université de Montréal's affiliated hospital research center ...

Surgery

Research uncovers key bariatric surgery complication cause

Postprandial hypoglycemia is one of the main complications of bariatric surgery and can affect up to 30% of patients. Unlike ordinary hypoglycemia, in which low blood sugar is usually associated with little food, postprandial ...

Overweight & Obesity

Study links metal levels in urine to childhood obesity risk

Researchers from the Granada Biosanitary Research Institute and the University of Granada have revealed positive and negative associations between exposure to a combination of different metals and overweight and obesity in ...

Overweight & Obesity

Are weight loss drugs like Ozempic, Wegovy safe for kids?

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as an alternative to the traditional—and often ineffective—advice to "eat less and exercise more."

Health

Weight loss brings Americans big health care savings

The advent of GLP-1 weight-loss medications such as Wegovy and Zepbound has spurred debate as to whether the drugs' cost should be covered by Medicare, Medicaid and private insurers.

Overweight & Obesity

Paternal weight associated with baby's size at birth, study finds

A study in Brazil involving 89 father-mother-baby triads points to an association between paternal overweight and newborn birth weight: the higher the father's body mass index (BMI, weight divided by height squared), the ...

Overweight & Obesity

Why some people don't lose weight with Wegovy

Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.